DN
David Nierengarten Wedbush Latest Price Targets & Analyst Ratings
Main Sector
Healthcare
Ratings Past Year
52
Avg Return
Past Year
Past Year
17%
Success Rate
Past Year
Past Year
0
%
Rating Distribution
Past 3 Months
Positive
91.7%
Neutral
0%
Negative
8.3%
Past Week
Past Month
Past 3 Months
Past 6 Months
Past Year
All Time
Positive
Neutral
Negative
Large Cap
$10B to $200B
Mid Cap
$2B to $10B
Small Cap
$250M to $2B
Micro Cap
Under $250M
Consumer Discretionary
Healthcare
Technology
Consumer Discretionary
Residential Construction
Restaurants
Healthcare
Biotechnology
Drug Manufacturers - General
Drug Manufacturers - Specialty & Generic
Medical Devices
Medical Instruments & Supplies
Technology
Solar
| Stock | Rating | Price Target |
Upside Downside |
Ratings 3 Months |
Avg Return 1 Year |
Success Rate 1 Year | Date | |
|---|---|---|---|---|---|---|---|---|
|
Outperform
Reiterated
| $1,000 |
18%
upside
| 2 | +4.6% |
0
%
| 9 Mar ‘26 1 month ago |
|
|
|
Outperform
Maintained
| $8 |
6%
upside
| 1 | +123% |
0
%
| 6 Mar ‘26 1 month ago |
|
|
|
Outperform
Maintained
| $5 |
320%
upside
| 1 | -0.93% |
0
%
| 5 Mar ‘26 1 month ago |
|
|
|
Outperform
Maintained
| $95 |
3%
upside
| 1 | -0.34% |
0
%
| 3 Mar ‘26 1 month ago |
|
|
|
Outperform
Maintained
| $65 |
107%
upside
| 1 | -20% |
0
%
| 25 Feb ‘26 1 month ago |
|
|
|
Outperform
Maintained
| $53 |
18%
upside
| 2 | +26% |
0
%
| 25 Feb ‘26 1 month ago |
|
|
|
Outperform
Reiterated
| $20 |
86%
upside
| 2 | +5.3% |
0
%
| 24 Feb ‘26 1 month ago |
|
|
|
Underperform
Initiated
| $110 |
8%
downside
| 1 | +7.8% |
0
%
| 24 Feb ‘26 1 month ago |
|
|
|
Outperform
Maintained
| $88 |
23%
upside
| 1 | -8% |
0
%
| 17 Feb ‘26 2 months ago |
|
|
|
Outperform
Reiterated
| $11 |
117%
upside
| 1 | +19% |
0
%
| 10 Feb ‘26 2 months ago |
|
|
|
Outperform
Reiterated
| $11 |
162%
upside
| 1 | +33% |
0
%
| 30 Jan ‘26 2 months ago |
|
|
|
Outperform
Reiterated
| $55 |
48%
upside
| 1 | -10% |
0
%
| 21 Jan ‘26 2 months ago |
|